JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1474.0
  • +25.5+1.76%
20min DelayMarket Closed May 2 15:30 JST
504.19BMarket Cap20.37P/E (Static)

About Santen Pharmaceutical Company

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Company Profile

Symbol4536
Company NameSanten Pharmaceutical
Founded1925-07-04
MarketTSE Prime
Employees3841
Fiscal Year Ends03-31
AddressGrand Front Osaka Tower A 4-20 Ofuka-cho, Kita-ku
Zip Code530-8552
Phone06-7664-8621

Company Executives

  • Name
  • Position
  • Salary
  • Takeshi Ito
  • Director, President and Chief Executive Officer
  • --
  • Rie Nakajima
  • Director, Head of China Business, Corporate Officer and Chief Operating Officer
  • --
  • Ippei Kurihara
  • Director, Corporate Officer, Head of Japan Business and Head of Global Commercial Strategy
  • --
  • Akira Kurokawa
  • Chairman of the Board
  • --
  • Tamie Minami
  • Independent Director
  • --
  • Noboru Kotani
  • Independent Director
  • --
  • Minoru Kikuoka
  • Independent Director
  • --
  • Masahiko Ikaga
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More